Citius Oncology, Inc.
Support and Resistance Levels
Past performance
News About CTOR
All events for CTOR
All deals for CTOR
Financial Ratios
Financial Statements
CTOR vs Sector & Peers
About Citius Oncology, Inc.
Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc. Headquarters Cranford, NY, US